Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Cell Lysis & Disruption market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Cell Lysis & Disruption market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Cell Lysis & Disruption market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Cell Lysis & Disruption products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Cell Lysis & Disruption products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Cell Lysis & Disruption market.
To learn more about this report
Increasing research and development spending on Cell Lysis & Disruption development has been the leading industry trend of Cell Lysis & Disruption market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Mammalian cells, Bacterial cells, Yeast/Algae/Fungi, Plant cells |
| By Application Outlook | Protein Isolation, Downstream Processing, Cell Organelle Isolation, Nucleic Acid Isolation |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Thermo Fisher Scientific, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd., Qiagen NV, Becton Dickinson & Company (BD), Danaher Corp., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Claremont BioSolutions, LLC, Microfluidics International Corp., Parr Instrument Company, BioVision, Inc., Covaris, Inc., Qsonica LLC |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Cell Lysis & Disruption Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Cell Lysis & Disruption Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Cell Lysis & Disruption Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Cell Lysis & Disruption Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Mammalian cells
4.2.2 Bacterial cells
4.2.3 Yeast/Algae/Fungi
4.2.4 Plant cells
4.4 Type Comparison Matrix
4.5 Global Cell Lysis & Disruption Market Attractiveness, By Type
5 Global Cell Lysis & Disruption Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Cell Lysis & Disruption Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Protein Isolation
5.3.2 Downstream Processing
5.3.3 Cell Organelle Isolation
5.3.4 Nucleic Acid Isolation
5.4 Application Comparison Matrix
5.5 Global Cell Lysis & Disruption Market Attractiveness, by Application
6 Global Cell Lysis & Disruption Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Cell Lysis & Disruption Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Cell Lysis & Disruption Market Attractiveness, by Region
8 North America Cell Lysis & Disruption Market Analysis and Forecast
8.1 Key Findings
8.2 North America Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Mammalian cells
8.2.2 Bacterial cells
8.2.3 Yeast/Algae/Fungi
8.2.4 Plant cells
8.3 North America Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Protein Isolation
8.3.2 Downstream Processing
8.3.3 Cell Organelle Isolation
8.3.4 Nucleic Acid Isolation
8.4 North America Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Cell Lysis & Disruption Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Cell Lysis & Disruption Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Mammalian cells
9.2.2 Bacterial cells
9.2.3 Yeast/Algae/Fungi
9.2.4 Plant cells
9.3 Europe Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Protein Isolation
9.3.2 Downstream Processing
9.3.3 Cell Organelle Isolation
9.3.4 Nucleic Acid Isolation
9.4 Europe Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Cell Lysis & Disruption Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Cell Lysis & Disruption Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Mammalian cells
10.2.2 Bacterial cells
10.2.3 Yeast/Algae/Fungi
10.2.4 Plant cells
10.3 Asia Pacific Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Protein Isolation
10.3.2 Downstream Processing
10.3.3 Cell Organelle Isolation
10.3.4 Nucleic Acid Isolation
10.4 Asia Pacific Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Cell Lysis & Disruption Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Cell Lysis & Disruption Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Mammalian cells
11.2.2 Bacterial cells
11.2.3 Yeast/Algae/Fungi
11.2.4 Plant cells
11.3 Latin America Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Protein Isolation
11.3.2 Downstream Processing
11.3.3 Cell Organelle Isolation
11.3.4 Nucleic Acid Isolation
11.4 Latin America Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Cell Lysis & Disruption Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Cell Lysis & Disruption Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Mammalian cells
12.2.2 Bacterial cells
12.2.3 Yeast/Algae/Fungi
12.2.4 Plant cells
12.3 Middle East & Africa (MEA) Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Protein Isolation
12.3.2 Downstream Processing
12.3.3 Cell Organelle Isolation
12.3.4 Nucleic Acid Isolation
12.4 Middle East & Africa (MEA) Cell Lysis & Disruption Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Cell Lysis & Disruption Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Thermo Fisher Scientific
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Inc.
13.3.3 Merck KGaA
13.3.4 F. Hoffmann-La Roche Ltd.
13.3.5 Qiagen NV
13.3.6 Becton Dickinson & Company (BD)
13.3.7 Danaher Corp.
13.3.8 Bio-Rad Laboratories
13.3.9 Inc.
13.3.10 Miltenyi Biotec GmbH
13.3.11 Claremont BioSolutions
13.3.12 LLC
13.3.13 Microfluidics International Corp.
13.3.14 Parr Instrument Company
13.3.15 BioVision
13.3.16 Inc.
13.3.17 Covaris
13.3.18 Inc.
13.3.19 Qsonica LLC
14 Key Takeaways
Choose License Type